Literature DB >> 20708969

Is SELDI-TOF a valid tool for diagnostic biomarkers?

Momar Ndao1, Adam Rainczuk, Marie-Claire Rioux, Terry W Spithill, Brian J Ward.   

Abstract

The genome revolution is providing fresh insights into host and parasite genomes, and new tools are becoming available for examining host-parasite interactions at the proteome level. Technologies such as surface-enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) can be applied to discover biomarkers (alterations in both host and parasite proteomes) associated with parasitic diseases. Such biomarkers can represent host proteins, fragments of host proteins or parasite proteins that appear in body fluids or tissues following infection. Individual biomarkers or biomarker patterns not only have diagnostic utility (e.g. in active disease, prognosis, tests of cure) but can also provide unique insights into the mechanisms underlying host responses and pathogenesis.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708969     DOI: 10.1016/j.pt.2010.07.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  4 in total

1.  Recent advances in clinical parasitology diagnostics.

Authors:  Cedric P Yansouni; Joanna Merckx; Michael D Libman; Momar Ndao
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

2.  Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.

Authors:  Brian Dean
Journal:  Schizophr Res Treatment       Date:  2011-06-18

Review 3.  Protein microarrays and biomarkers of infectious disease.

Authors:  Mohan Natesan; Robert G Ulrich
Journal:  Int J Mol Sci       Date:  2010-12-16       Impact factor: 5.923

4.  Serum biomarkers predictive of cure in Chagas disease patients after nifurtimox treatment.

Authors:  Cynthia Santamaria; Eric Chatelain; Yves Jackson; Qianqian Miao; Brian J Ward; François Chappuis; Momar Ndao
Journal:  BMC Infect Dis       Date:  2014-06-03       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.